These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7813702)

  • 1. Hepatitis B in children in Italy: incidence and risk factors: SEIEVA Collaborating Group. Sistema Epidemiologico Integrato dell'Epatite virale Acuta.
    Corona R; Gandolfi C; Ferrigno L; Sagliocca L; Ciaralli F; Martelli A; Galanti C; Moiraghi A; Palumbo F; Novaco F
    Eur J Epidemiol; 1994 Apr; 10(2):219-22. PubMed ID: 7813702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Social determinants and risk of acute viral hepatitis].
    Malvasio P; Russo R; Zotti C; Vigna I; Ruggenini Moiraghi A
    Ann Ist Super Sanita; 1998; 34(4):489-94. PubMed ID: 10234880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline of incidence of A, B and non-A, non-B hepatitis in Italy. Results of four years surveillance (1985-88). SEIEVA collaborating group.
    Mele A; Stazi MA; Corona R; Ferrigno L; Sagliocca L; Palumbo F; Falasca P; Galanti C; Moiraghi A; Rosmini F
    Ital J Gastroenterol; 1990 Oct; 22(5):274-80. PubMed ID: 2134326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of hepatitis B in Italy: lessons from surveillance of type-specific acute viral hepatitis. SEIEVA Collaborating Group.
    Mele A; Stazi MA; Gill ON; Pasquini P
    Epidemiol Infect; 1990 Feb; 104(1):135-41. PubMed ID: 2307181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy.
    Stroffolini T; Mele A; Tosti ME; Gallo G; Balocchini E; Ragni P; Santonastasi F; Marzolini A; Ciccozzi M; Moiraghi A
    J Hepatol; 2000 Dec; 33(6):980-5. PubMed ID: 11131462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign.
    Mele A; Mariano A; Tosti ME; Stroffolini T; Pizzuti R; Gallo G; Ragni P; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2007 Feb; 44(3):e17-24. PubMed ID: 17205431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors of acute Delta hepatitis in Italy: results from a national surveillance system. SEIEVA Collaborating Group.
    Stroffolini T; Ferrigno L; Cialdea L; Catapano R; Palumbo F; Novaco F; Moiraghi A; Galanti C; Bernacchia R; Mele A
    J Hepatol; 1994 Dec; 21(6):1123-6. PubMed ID: 7699238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of and risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. SEIEVA Collaborating Group.
    Mele A; Stroffolini T; Palumbo F; Gallo G; Ragni P; Balocchini E; Tosti ME; Corona R; Marzolini A; Moiraghi A
    J Hepatol; 1997 Apr; 26(4):743-7. PubMed ID: 9126784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
    Mele A; Stroffolini T; Zanetti AR
    J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hepatitis A in Italy: incidence, risk factors and preventive measures.
    Tosti ME; Spada E; Romanò L; Zanetti A; Mele A;
    J Viral Hepat; 2008 Oct; 15 Suppl 2():26-32. PubMed ID: 18837830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Hepatitis B Vaccination Campaign in Italy: Towards the Control of HBV Infection for the First Time in a European Country.
    Stroffolini T; Morisco F; Ferrigno L; Pontillo G; Iantosca G; Cossiga V; Crateri S; Tosti ME; The Seieva Collaborating Group
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated epidemiological system for acute viral hepatitis in Italy (SEIEVA): description and preliminary results.
    Mele A; Rosmini F; Zampieri A; Gill ON
    Eur J Epidemiol; 1986 Dec; 2(4):300-4. PubMed ID: 3100322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on hepatitis B vaccination in Italy 10 years after its implementation.
    Zanetti AR
    Vaccine; 2001 Mar; 19(17-19):2380-3. PubMed ID: 11257364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for the infant and adolescent vaccination programmes in Italy.
    Da Villa G
    Vaccine; 2000 Feb; 18 Suppl 1():S31-4. PubMed ID: 10683541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Travel-associated hepatitis A: effect of place of residence and country visited.
    Mele A; Sagliocca L; Palumbo F; Stazi MA; Rosmini F; Ferrigno L; Corona R; Osborn J; Gill ON; Pasquini P
    J Public Health Med; 1991 Nov; 13(4):256-9. PubMed ID: 1764281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of timeliness, representativeness and quality of data reported to Italy's national integrated surveillance system for acute viral hepatitis (SEIEVA).
    Tosti ME; Longhi S; de Waure C; Mele A; Franco E; Ricciardi W; Filia A
    Public Health; 2015 May; 129(5):561-8. PubMed ID: 25795017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy.
    La Torre G; Nicolotti N; de Waure C; Chiaradia G; Specchia ML; Mannocci A; Ricciardi W
    Virol J; 2008 Jul; 5():84. PubMed ID: 18652653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.